Keyphrases
18F-FDG PET-CT
100%
Administrators
12%
Assessment Change
12%
Biopsy-proven
12%
Clinical Assessment
37%
Clinical Impact
12%
Clinical Suspicion
25%
Clinical Treatment
12%
FDG-PET Scan
25%
Impact on Patients
12%
Institutional Review Board
12%
Lung Cancer
100%
Medicaid
12%
Medicare
25%
Patient Management
100%
PET Scan
100%
Positron Emission Tomography-computed Tomography (PET-CT)
12%
Recurrence or Metastasis
37%
Tertiary Care Hospital
12%
Treatment Change
25%
Tumor Subtype
12%
Medicine and Dentistry
Biopsy Technique
7%
Clinical Assessment
23%
Fluorodeoxyglucose F 18
100%
Lung Cancer
100%
Medicare
15%
Metastatic Carcinoma
23%
Neoplasm
7%
Patient Care
100%
Positron Emission Tomography-Computed Tomography
100%
Recurrent Disease
23%
Retrospective Study
7%
Pharmacology, Toxicology and Pharmaceutical Science
Fluorodeoxyglucose F 18
100%
Lung Cancer
100%
Neoplasm
7%
Polyethylene Terephthalate
100%
Recurrent Disease
23%
Retrospective Study
7%
Neuroscience
Clinical Assessment
23%
Fluorine-18
100%
Positron Emission Tomography-Computed Tomography
100%
Immunology and Microbiology
Positron Emission Tomography-Computed Tomography
100%
X-Ray Computed Tomography
76%